ORGANIGRAM GLOBAL INC.
For the period ended Sep 30, 2024. Filed Dec 18, 2024.
View on SEC.govAbout this filing
The yearly report of certain Canadian companies, filed under a joint US and Canadian system. It is the main yearly account these companies give US investors, largely as filed in Canada.
FY2024 · Filed Dec 18, 2024
Use the contents to explore the available documents and sections.
Contents
EX-99.5 · PRODUCT DEVELOPMENT COLLABORATION
PRODUCT DEVELOPMENT COLLABORATION
On March 10, 2021, in conjunction with the strategic investment we received from BAT, the Company and BAT entered into the PDC Agreement pursuant to which the CoE was established at the Moncton Campus to focus on developing the next generation of cannabis products.
Pursuant to the terms of the PDC Agreement, $31,109 of BAT's original investment in the Company was reserved as restricted cash in order to satisfy certain of the Company’s future obligations under the PDC Agreement, including the Company’s portion of its funding obligations under a mutually agreed initial budget for the CoE. Costs relating to the CoE are funded equally by the Company and BAT. Balances are transferred from restricted cash to the Company's general operating account as CoE related expenditures are periodically reconciled and approved. The balance in restricted cash as at September 30, 2024 is $25,860 (September 30, 2023 - $17,893).
The CoE is accounted for as a joint operation, with the Company and BAT each paying 50% of the costs incurred by the CoE.. For theyear ended September 30, 2024, $6,666(September 30, 2023 - $6,886) of expenses have been recorded in the statements of operations andcomprehensive loss.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.